Neurenati Therapeutics
Neurenati Therapeutics is a biotechnology company that develops therapeutics for gastrointestinal rare diseases.
Based, Neurenati Therapeutics works in biotechnology, medical, therapeutics, founded in 2020.
The company sits in the biotechnology, medical, therapeutics segment, where it competes on its core product or service.
Directory data places it at the Seed stage.
The company reports a headcount in the c_00001_00010 range.
Public records show total funding of about $2.6M.
| Sector | Biotechnology, Medical, Therapeutics |
|---|---|
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $2,584,399 |
Website: www.neurenati.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account